Table 3. Characterization of the MRI report of the CIDPabnl group.

n = 9	MRI report/CNS involvement	Cranial nerves involved	Other conditions	Current treatment*
Patient 1	Cerebellar atrophy	−	Systemic arterial hypertension	Intravenous immunoglobulin
Patient 2	Mild cerebellar atrophy, reduction in corpus callosum thickness	−	−	Intravenous immunoglobulin
Patient 3	Cerebellar atrophy	Trigeminal nerve	Monoclonal gammopathy of undetermined significance	Methylprednisolone
Patient 4	periarteriolar demyelinatin features	−	−	Gabapentin
Patient 5	occipital demyelination	Trigeminal nerve	−	Methylprednisolone
Patient 6	Cerebellar atrophy, brain atrophy, microangiopathy	−	−	Intravenous immunoglobulin
Patient 7	Cerebellar atrophy	−	−	Carbamazepine
Patient 8	Cerebral parenchyma, microangiopathy	−	−	Intravenous immunoglobulin
Patient 9	Cerebellar atrophy	−	−	Intravenous immunoglobulin

Note: *The last three months; Only the principal treatment is described.